| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | NUVASIVE INC | 1,487,000 | 72,343,000 | 0.76% | ||
| 102 | INSYS THERAPEUTICS INC NEW COM NEW | 4,557,740 | 72,878,000 | 0.77% | ||
| 103 | CORVUS PHARMACEUTICALS INC COM | 5,258,450 | 76,248,000 | 0.80% | ||
| 104 | MALLINCKRODT PUB LTD CO | 1,309,000 | 80,216,000 | 0.84% | ||
| 105 | PUMA BIOTECHNOLOGY | 2,753,425 | 80,868,000 | 0.85% | ||
| 106 | TESARO INCORPORATED | 1,912,000 | 84,185,000 | 0.89% | ||
| 107 | BIOMARIN PHARMACEUTICAL INC | 1,023,200 | 84,394,000 | 0.89% | ||
| 108 | OPHTHOTECH CORP | 2,094,500 | 88,535,000 | 0.93% | ||
| 109 | ACHILLION PHARMACEUTICALS IN | 11,519,700 | 88,932,000 | 0.94% | ||
| 110 | ALLERGAN PLC | 104,200 | 95,774,000 | 1.01% | ||
| 111 | RELYPSA INC | 7,400,000 | 100,270,000 | 1.06% | ||
| 112 | UNITEDHEALTH GROUP INC | 812,000 | 104,667,000 | 1.10% | ||
| 113 | NEUROCRINE BIOSCIE COM USD0.001 | 2,653,874 | 104,961,000 | 1.10% | ||
| 114 | PFIZER INC | 4,122,000 | 122,176,000 | 1.29% | ||
| 115 | COOPER COS INC | 795,900 | 122,545,000 | 1.29% | ||
| 116 | IRONWOOD PHARMACEUTICALS INC | 11,550,400 | 126,361,000 | 1.33% | ||
| 117 | MAGELLAN HEALTH INC COM NEW | 1,909,000 | 129,678,000 | 1.36% | ||
| 118 | Wright Medical Group NV | 8,345,110 | 138,529,000 | 1.46% | ||
| 119 | AGILENT TECHNOLOGIES INC | 3,495,000 | 139,276,000 | 1.47% | ||
| 120 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,120,000 | 143,886,000 | 1.51% | ||
| 121 | TEVA PHARMACEUTICAL INDS LTD | 2,696,000 | 144,263,000 | 1.52% | ||
| 122 | ILLUMINA INC | 900,000 | 145,899,000 | 1.54% | ||
| 123 | VERTEX PHARMACEUTICALS INC | 1,869,400 | 148,599,000 | 1.56% | ||
| 124 | EXPRESS SCRIPTS HLDG CO | 2,421,000 | 166,298,000 | 1.75% | ||
| 125 | INTUITIVE SURGICAL INC | 276,800 | 166,371,000 | 1.75% | ||
| 126 | WELLCARE HEALTH PLANS INC | 1,903,300 | 176,531,000 | 1.86% | ||
| 127 | LILLY ELI & CO | 2,541,300 | 182,999,000 | 1.93% | ||
| 128 | REGENERON PHARMACEUTICALS | 533,000 | 192,115,000 | 2.02% | ||
| 129 | INCYTE CORP | 2,755,078 | 199,661,000 | 2.10% | ||
| 130 | THERMO FISHER SCIENTIFIC INC | 1,435,000 | 203,182,000 | 2.14% | ||
| 131 | IMPAX LABORATORIES INC | 6,776,100 | 216,971,000 | 2.28% | ||
| 132 | ALEXION PHARMACEUTIC | 1,870,600 | 260,425,000 | 2.74% | ||
| 133 | GILEAD SCIENCES INC | 3,019,200 | 277,344,000 | 2.92% | ||
| 134 | CELGENE CORP | 3,774,077 | 377,747,000 | 3.97% | ||
| 135 | BIOGEN INC | 1,526,300 | 397,326,000 | 4.18% | ||
| 136 | ALLERGAN PLC | 1,572,715 | 421,535,000 | 4.44% | ||
| 137 | ABBVIE INC | 7,395,700 | 422,442,000 | 4.45% | ||
| 138 | BOSTON SCIENTIFIC CORP | 22,479,700 | 422,843,000 | 4.45% | ||
| 139 | AMGEN INC | 2,876,000 | 431,199,000 | 4.54% | ||
| 140 | HCA HOLDINGS INC | 5,737,100 | 447,781,000 | 4.71% | ||
| 141 | BRISTOL MYERS SQUIBB CO | 7,624,900 | 487,079,000 | 5.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003439, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
